21st.BIO files EU Novel Food application for BLG Essential+™ and calls for a European home market for industrially proven precision fermentation technology for production of food

Barchart · 3d ago

21st.BIOs Novel Food application for the milk protein beta-lactoglobulin (BLG), marks a significant step toward producing high-quality proteins in Europe with fewer resources while helping address supply constraints in the European whey protein market. When approved by EFSA, 21st.BIO's BLG Essential+ can enable resource-efficient milk protein production and sale in Europe using industrially proven precision fermentation technology. This highlights the need for a predictable, fast-track EU approval process for well-characterized, nature-identical food proteins produced using technologies with a demonstrated safety record.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.